Table 5.
Herb | Drug or Drug Class | Interaction or Other Comments |
---|---|---|
Comfrey | Phenobarbital | Increases metabolism of comfrey, producing a lethal metabolite from pyrrolizidine that results in severe hepatotoxicity |
Danshen | Anticoagulants or antiplatelets | Increases bleeding due to additive effects |
Digoxin | Increases side effects of digoxin | |
Echinacea | Amiodarone or ibutilide | Increases QT interval |
Statins, fibrates, niacin | Increases risk of hepatotoxic effects | |
Ephedra | Antidiabetes drugs | Increases blood glucose; Decreases effectiveness of oral hypoglycemic agents |
Class IA and class III antiarrhythmics | Increases QT interval | |
β-Blockers | Decreases effects of β-blockers, leading to hypertension and tachycardia | |
Monoamine oxidase inhibitors | Hypertension | |
Evening primrose oil | Phenobarbital | Decreases seizure threshold |
Garlic | Aspirin, clopidogrel, warfarin, or heparinoids | Increases bleeding risk |
Ginkgo biloba | Antidiabetes drugs | Increases hypoglycemia |
Aspirin | Increases bleeding; inhibits PAF hemorrhage | |
Warfarin | ||
Ginseng | Antidiabetes drugs | Increases hypoglycemia |
Digoxin | Interferes with digoxin assay, leading to falsely increased levels | |
Warfarin | Decreases effectiveness of warfarin | |
Phenelzine sulfate | Headache; Irritability; Insomnia |
|
Hawthorn | Digoxin | Increases effects of digoxin |
Calcium channel blockers or nitrates | Increases coronary vasodilatory effects | |
Kava | Alprazolam | Increases CNS depression; Increases effects of alcohol |
Licorice | Spironolactone | Increases effects of spironolactone |
Saw palmetto | Anticoagulants or antiplatelets | Increases bleeding |
Soy milk | Warfarin | Decreases effectiveness of warfarin |
St. John’s wort | Digoxin | Decreases serum digoxin concentration |
Clopidogrel | Increases activity of clopidogrel; Increases bleeding |
|
Warfarin | Decreases warfarin bioavailability and effectiveness | |
Simvastatin | Decreases effectiveness of simvastatin | |
Paroxetine | Nausea; Lethargy; Incoherence |
|
Class IA and III antiarrhythmic agents | Decreases effectiveness (precipitating arrhythmias) | |
Cyclosporine | Decreases cyclosporine concentration due to increased clearance (transplant rejection) | |
Theophylline | Decreases serum concentration | |
Indinavir | Decreases serum concentration (treatment failure in HIV patients) | |
Yohimbine | Clonidine | Decreases blood pressure reduction effect of centrally active agents |
Guanabenz | ||
CNS stimulants (eg, amphetamines) | Risk of hypertensive crisis due to its monoamine oxidase inhibitor activity | |
ACE inhibitors | Decreases effectiveness of ACE inhibitors; Hypertension |
|
β-Blockers | Decreases effectiveness of β-blockers; Hypertension; Increases heart rate |
Abbreviations: ACE, angiotensin-converting enzyme; CNS, central nervous system; HIV, human immunodeficiency virus; PAF, platelet-activating factor.